(Vienna, 02-04-2025) Julia Binder, Associate Professor at the Clinical Department of Obstetrics and Feto-Maternal Medicine at the Medical University of Vienna, has been recognized as a finalist for the prestigious Medis Awards. Her work on the prognostic significance of angiogenic markers in pregnancies with fetal growth restriction (FGR) provides promising insights for clinical practice and is now receiving international recognition.
Fetal growth restriction is one of the most common and most severe pregnancy complications. It can significantly increase the risk of perinatal morbidity and mortality and is closely associated with preeclampsia – a condition characterised by high blood pressure and organ damage during pregnancy.
In her award-winning study entitled "Prognostic Value of Angiogenic Markers in Pregnancy with Fetal Growth Restriction" (published in "Ultrasound in Obstetrics & Gynecology"), Julia Binder identifies new angiogenic biomarkers that can help to better assess the risk of FGR in patients. These markers enable an early differentiation between pregnancies with and without the threat of preeclampsia. This could help to avoid unnecessary medical interventions and, at the same time, provide targeted care for high-risk patients.
"Our research shows that angiogenic markers can be valuable predictive indicators. They enable personalised care for pregnant women with fetal growth restriction and could influence clinical guidelines in the long term," explains Julia Binder.
Julia Binder is an expert in the field of fetomaternal medicine. After completing her specialist medical training, she completed fellowships in fetal medicine at St. George's Hospital in London and in fetomaternal medicine at the Medical University of Vienna. She completed her habilitation in 2021 with a thesis on angiogenic markers and maternal hemodynamics in hypertensive pregnancy disorders. She heads the preeclampsia research group at the Medical University of Vienna.
Julia Binder's latest findings open up new perspectives in prenatal medicine and provide a basis for further research. Her work contributes to improving the care of pregnant women with FGR and to identifying possible risks at an early stage.
The International Medis Awards for Medical Research are an annual international competition for doctors and pharmacists who have published medical research results in a specific medical field in a high-ranking scientific publication and are actively involved in clinical practice at institutions throughout the region on a daily basis. The award ceremonies take place in a different host country each year. The submitted scientific research papers are evaluated by an independent international scientific committee.